MITCHELL P RALES
CIK 1015014 · Executive Chair of Board · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.20B
Companies
7
Total Filings
74
Lifetime Open-Market Net
-$1.33B
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ESAB | Executive Chair of Board | 3,554,229 | $85.09 | $302.43M | $20.00M | 12 | 2026-07-02 |
| DHR | Chairman of Exec. Committee | 54,029 | $195.78 | $10.58M | -$581.05M | 28 | 2026-02-27 |
| Enovis CORP (CFX) Delisted | Director | 2,914,099 | $117.18 | $341.47M | -$134.51M | 11 | 2022-01-19 |
| Enovis CORP (CFXA) Delisted | Director | 1,169,991 | $177.71 | $207.92M | $11.56M | 1 | 2021-08-04 |
| FTV | Director | 15,944,993 | $58.43 | $931.67M | -$694.80M | 9 | 2020-08-12 |
| XRAY | Chairman of Exec. Committee | 45,422,215 | $13.76 | $625.01M | $2.12M | 3 | 2015-01-29 |
| ENOV | Director | 11,321,361 | $29.30 | $331.72M | $50.00M | 1 | 2012-01-26 |
Recent Filings · Page 4 of 8
74 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-17 | ENOV | Notice (144) | −1,088,756 | -$60.74M | EDGAR |
| 2023-04-18 | DHR | Conv (C) | +50,175 | $10.00M | EDGAR |
| 2023-02-03 | DHR | Grant (A) | — | $0 | EDGAR |
| 2023-01-03 | DHR | Grant (A) | — | $0 | EDGAR |
| 2022-11-17 | ESAB | Buy (P) | +500,000 | $20.00M | EDGAR |
| 2022-05-17 | DHR | Buy (P) | +100 | $24.8K | EDGAR |
| 2022-02-03 | DHR | Grant (A) | — | $0 | EDGAR |
| 2022-01-19 | Enovis CORP (CFX) Delisted | Conv (C) | +1,600,000 | $0 | EDGAR |
| 2022-01-04 | DHR | Grant (A) | — | $0 | EDGAR |
| 2021-11-04 | DHR | Sell (S) | −1,225,841 | -$377.91M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.